Oryzon Genomics S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
October 27, 2023 at 12:12 pm EDT
Oryzon Genomics S.A. reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported net loss was USD 1.13 million compared to USD 0.618 million a year ago. Basic loss per share from continuing operations was USD 0.02 compared to USD 0.01 a year ago.
For the nine months, net loss was USD 1.73 million compared to USD 1.88 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.04 a year ago.